Back to search

Article

Senolytic effects of Moringa oleifera leaf extract in an in vitro model of Alzheimer’s disease

2026-03-25

Abstract excerpt

<title>Abstract</title> <p> Accumulation of senescent cells (SnCs) in the aging brain contributes to Alzheimer's disease (AD) progression through the secretion of senescence-associated secretory phenotype (SASP) that exacerbates neuroinflammation and neurodegeneration. Senolytic agents that selectively eliminate SnCs, have emerged as a potential therapeutic strategy, however safer natural alternatives remain und...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c2deba03-cd57-58bf-b421-bd16c52a2fef
DOI
10.21203/rs.3.rs-9082466/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Senolytic effects of Moringa oleifera leaf extract in an in vitro model of Alzheimer’s diseaseDOI 10.21203/rs.3.rs-9082466/v1
Targeting cellular senescence with senotherapeutics: senolytics and senomorphicsSemantic proximity
Targeting Senescence: A Review of Senolytics and Senomorphics in Anti-Aging InterventionsSemantic proximity
Novel Senolytic Ingredient, Camellia sinensis Root Extract, Ameliorates Skin Aging-Associated PhenotypesSemantic proximity
Aging, Senescence, and DementiaSemantic proximity
Senotherapeutics to Counteract Senescent Cells Are Prominent Topics in the Context of Anti-Ageing StrategiesSemantic proximity
The Role of Nutraceuticals and Functional Foods in Mitigating Cellular Senescence and Its Related Aspects: A Key Strategy for Delaying or Preventing Aging and Neurodegenerative DisordersSemantic proximity
Recent Advances in Senolysis for Age-Related DiseasesSemantic proximity
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span.Semantic proximity
A second generation of senotherapies: the development of targeted senolytics, senoblockers and senoreversers for healthy ageingSemantic proximity
Cell senescence in neuropathology: A focus on neurodegeneration and tumoursSemantic proximity
Current senolytics: Mode of action, efficacy and limitations, and their future.Semantic proximity
Discovery, development, and future application of senolytics: theories and predictions.Semantic proximity
Select a neighboring publication to make it the new centre.